VCM
FLNA

Voleon Capital Management’s Filana Therapeutics FLNA Stock Holding History

Voleon Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-142,385
Closed -$414K – 1001
2025
Q3 		$414K Buy
+142,385
New +$327K 0.01% 634

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Voleon Capital Management's FLNA Position: Q4 2025 in Review

Voleon Capital Management sold out of Filana Therapeutics (FLNA) in Q4 2025, closing a stake of 142,385 shares — an estimated $414K sold.

Voleon Capital Management first reported a position in FLNA in Q3 2025 and held it in 1 quarter. The position peaked at $414K in Q3 2025. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.

  • Voleon Capital Management reported no remaining Filana Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Voleon Capital Management sold 142,385 Filana Therapeutics shares in Q4 2025, an estimated $414K.
  • Voleon Capital Management first reported a position in Filana Therapeutics in Q3 2025 and held it in 1 quarter.
  • Voleon Capital Management's Filana Therapeutics position peaked at $414K in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.

Based on Voleon Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.